Alkindi 欧盟 - 丹麦文 - EMA (European Medicines Agency)

alkindi

diurnal europe b.v. - hydrocortison - adrenal insufficiens - kortikosteroider til systemisk brug - udskiftning terapi af binyrebarkinsufficiens hos spædbørn, børn og unge (fra fødsel til < 18 år).

Alofisel 欧盟 - 丹麦文 - EMA (European Medicines Agency)

alofisel

takeda pharma a/s - darvadstrocel - rektal fistel - immunosuppressiva - alofisel er indiceret til behandling af komplekse endetarmsåbning fistler hos voksne patienter med ikke-aktive/mildt aktiv luminal crohn ' s sygdom, når fistler har vist et utilstrækkeligt respons på mindst én konventionelle eller biologiske terapi. alofisel bør anvendes efter konditionering af fistler.

Mycostop WP Vanddispergerbart pulver 丹麦 - 丹麦文 - SEGES Landbrug & Fødevarer

mycostop wp vanddispergerbart pulver

danstar ferment ag - streptomyces - vanddispergerbart pulver - 500000000000 cfu/kg streptomyces k61

Prestop WP Vanddispergerbart pulver 丹麦 - 丹麦文 - SEGES Landbrug & Fødevarer

prestop wp vanddispergerbart pulver

danstar ferment ag - clonostachys - vanddispergerbart pulver - 100000000000 cfu/kg clonostachys rosea stamme j1446 (=gliocladium catenulatum stamme j1446)

Carmustine medac (previously Carmustine Obvius) 欧盟 - 丹麦文 - EMA (European Medicines Agency)

carmustine medac (previously carmustine obvius)

medac gesellschaft für klinische spezialpräparate mbh - carmustin - hodgkin disease; lymphoma, non-hodgkin - antineoplastiske midler - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).

Baqsimi 欧盟 - 丹麦文 - EMA (European Medicines Agency)

baqsimi

eli lilly nederland b.v. - glucagon - diabetes mellitus - pancreas hormoner, hormoner glycogenolytic - baqsimi er indiceret til behandling af alvorlig hypoglykæmi hos voksne, unge og børn i alderen 4 år og derover med diabetes mellitus.

Gencebok 欧盟 - 丹麦文 - EMA (European Medicines Agency)

gencebok

gennisium pharma - koffeincitrat - apnø - psychoanaleptics, - behandling af primær apnø af præmature nyfødte.

Trixeo Aerosphere 欧盟 - 丹麦文 - EMA (European Medicines Agency)

trixeo aerosphere

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Libmeldy 欧盟 - 丹麦文 - EMA (European Medicines Agency)

libmeldy

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - andre narkotika stoffer - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

Palforzia 欧盟 - 丹麦文 - EMA (European Medicines Agency)

palforzia

aimmune therapeutics ireland limited - defatted powder of arachis hypogaea l., semen (peanuts) - peanut hypersensitivity - allergens - palforzia is indicated for the treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. palforzia may be continued in patients 18 years of age and older. palforzia should be used in conjunction with a peanut-avoidant diet.